medline.ch Gastroenterologie Pankreas Neoplasie

	FCGR2B (+) Macrophages as a Critical Node Linking Ferroptosis and Immunosuppression: A Multiomics Framework for Prognosis and Therapy in High-Grade Serous Ovarian Cancer. Hum Mutat Zhou J, Zeng T, Liu Y, Ye M, Li M, Zhang Z, Meng Y. PMID: 41953398 [PubMed - indexed for MEDLINE]
	Unconventional Medicine and Institutional Resistance: A Case History About the Uphill Battles Facing an Innovative Cancer Therapy. Integr Med (Encinitas) Isaacs LL. PMID: 41953061 [PubMed]
	Intranetwork variation in neoadjuvant therapy delivery for borderline resectable and locally advanced pancreatic cancer: a UK multicentre cohort study. Ann R Coll Surg Engl Labib PL, Alarabiyat M, Powell-Brett S, Hall L, Rehman S, Edwards D, Ma YT, Sivakumar S, Good J, Candish C, Nagy A, Tsalic M, Hafeez T, Kunene V, Chatterjee A, Roberts KJ, Chatzizacharias N. PMID: 41952607 [PubMed - as supplied by publisher]
	Preoperative Biliary Drainage with Metal Stent Versus Early Surgery in Patients with Pancreatic Cancer: A Randomized Clinical Trial. Ann Surg Oncol Costamagna G, Reddy DN, Chia NH, Itoi T, Devière J, Lee KF, Rao GV, Alfieri S, Lo I, Kasuya K, Closset J, Carr-Locke DL, Chandwani R, Peetermans J, Rousseau M, Lau J. PMID: 41951900 [PubMed - as supplied by publisher]
	Duodenal metastasis from lobular breast cancer presenting as painless obstructive jaundice. BMJ Case Rep Antonakis PT, Iliakopoulos K, Panopoulou E, Myoteri D, Vlahos I, Kozonis T, Kritsotakis E, Bramis K. PMID: 41951263 [PubMed - indexed for MEDLINE]
	Case Report: Discordant pancreatic inflammatory pseudotumor in a breast cancer survivor - a diagnostic dilemma. Front Oncol Cao Z, Lyu X, Lu X, Zhang T. PMID: 41948497 [PubMed]
	Dual role of exosomes in pancreatic cancer:Â Underlying mechanisms and research advances (Review). Oncol Lett Guo Z, Liu Q. PMID: 41947900 [PubMed]
	Development and validation of a nomogram for overall survival in pancreatic solid pseudopapillary neoplasm: a population-based study. Sci Rep Zhong P, Tao Q, Hu F. PMID: 41946935 [PubMed - indexed for MEDLINE]
	Trends and Disparities in the Use of Next-Generation Sequencing in Patients With Cancer in the United States. JAMA Netw Open Hage Chehade C, Ozay ZI, Jo Y, Gebrael G, Sayegh N, Ostrowski M, Srivastava A, Garg D, Hardy T, Murdock EG, Narang A, Mathew Thomas V, Li H, Maughan BL, Roy S, Agarwal N, Swami U. PMID: 41945343 [PubMed - indexed for MEDLINE]
	Pancreatic cancer-associated myofibroblasts: a review. Int J Biol Sci Banacki M, Inkielewicz-Stepniak I. PMID: 41943847 [PubMed - indexed for MEDLINE]
	Integrative multimodal transcriptomics identifies a cancer-associated fibroblast membrane signature for predicting prognosis and therapeutic response in pancreatic ductal adenocarcinoma. J Mol Med (Berl) Zhuang L, Zhang W, Wu J, Cao J, Feng L, Cao S. PMID: 41942785 [PubMed - indexed for MEDLINE]
	Emerging Therapeutic Landscapes for KRAS-Mutant Pancreatic Ductal Adenocarcinoma: Beyond the "Undruggable" Paradigm. Turk J Gastroenterol Li W, Lin X, Liu P, Zhang J, Liu C. PMID: 41942368 [PubMed - indexed for MEDLINE]
	Impact of immunosuppressive therapy on non-melanoma skin cancer after solid organ transplantation: A critical systematic review. Transpl Immunol Abulail JA, Husein SA, Al-Tamimia M, Jaradat M, Alhawamdeh S, Elkhalili Z, Esaid R, Saleh T, Al Shboul S. PMID: 41941970 [PubMed - as supplied by publisher]
	pRECIST: Guidelines for Response Criteria for Use in Trials Testing Therapeutics in Pancreatic Cancer. Pancreas Martin RCG 2nd, Scheon E, Govindarajan N, Verdeur M, Justin J, Shamsi K. PMID: 41941588 [PubMed - as supplied by publisher]
	Pancreatic cancer immunotherapy biomarkers: from traditional markers to multimodal integration and dynamic monitoring. Front Immunol Zhao WY, Zhao JW. PMID: 41939911 [PubMed - indexed for MEDLINE]
	Correction: Vimentin expression as a prognostic marker in pancreatic cancer: a systematic review and meta-analysis. Front Med (Lausanne) Cretu OI, Lungulescu CV, Gentiluomo M, Turcu-Stiolica A, Pani, Patrascu S, Ungureanu BS. PMID: 41939785 [PubMed]
	Radiotherapy as a partner for immunotherapy in pancreatic cancer: current landscape and future directions. Front Oncol Diao Z, Wang Y, Mu S, Wu X, Yu S, Wang Z. PMID: 41939454 [PubMed]
	Beyond conventional biomarkers: the role of alpha-fetoprotein in gastroenteropancreatic neuroendocrine neoplasms. Front Endocrinol (Lausanne) La Salvia A, Fanciulli G. PMID: 41938105 [PubMed - indexed for MEDLINE]
	Impact of Male Sex and Umbilical-Pancreatic Anatomy on Surgical Difficulty in Minimally Invasive Distal Pancreatectomy: A Propensity-Matched Analysis. Asian J Endosc Surg Fukada M, Mitsui N, Horaguchi T, Yasufuku I, Sato Y, Tajima JY, Tanaka Y, Matsuhashi N. PMID: 41936535 [PubMed - indexed for MEDLINE]
	Unmasking FCGR2B as a high-grade serous ovarian cancer specific marker of immune suppression and tumor progression through multi-omics mining. Transl Oncol Zhou J, Zeng T, Ye M, Li M, Wen L, Liu X, Zhang Z, Meng Y. PMID: 41934917 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 59643

Seite 1 von 2983

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung